V.F. Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 12, 2025 to Discuss Your Rights – VFC — Neutral
VFC GlobeNewsWire — October 28, 2025NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in V.F. Corporation ("V.F. Corporation" or the "Company") (NYSE: VFC) of a class action securities lawsuit.
Levi & Korsinsky Notifies Shareholders of KBR, Inc.(KBR) of a Class Action Lawsuit and an Upcoming Deadline — Neutral
KBR GlobeNewsWire — October 28, 2025NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in KBR, Inc. ("KBR, Inc." or the "Company") (NYSE: KBR) of a class action securities lawsuit.
Investors who lost money on Savara Inc. (SVRA) should contact Levi & Korsinsky about pending Class Action - SVRA — Neutral
SVRA GlobeNewsWire — October 28, 2025NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit.
Goldman Sachs projects currency realignments by 2035 — Neutral
GS Proactive Investors — October 28, 2025Goldman Sachs Group Inc (NYSE:GS, ETR:GOS) has released long-term foreign exchange forecasts through 2035, projecting shifts in both major and emerging market currencies as part of its broader analysis of structural investment trends. The firm's analysts project EUR/USD at 1.21, USD/JPY at 100, GBP/USD at 1.24, and USD/CNY at 5.17 by 2035.
Slide Insurance Holdings Investigation: Johnson Fistel has Commenced an Investigation on Behalf of Slide Insurance Shareholders — Neutral
SLDE GlobeNewsWire — October 28, 2025SAN DIEGO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Slide Insurance Holdings, Inc. (NASDAQ: SLDE) or any of its executive officers violated securities laws by misrepresenting or failing to disclose material information to investors. What is this all about? Shares of Slide Insurance have fallen over 25% since the Company's June IPO. On September 30, a Manatee Research report alleged that Slide's underwriting margins are driven by claim denials and delays, rather than the "proprietary technology" previously touted by the Company. The report also claims that Florida regulators ordered the removal …
Investors in Cytokinetics, Incorporated Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights – CYTK — Neutral
CYTK GlobeNewsWire — October 28, 2025NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) of a class action securities lawsuit.
Nvidia Says It's Adding This Tech Company to Its Investment Portfolio. The Stocks Are Surging. — Positive
NOK Investopedia — October 28, 2025A vote of confidence from AI chipmaker Nvidia is sending shares of another tech company soaring Tuesday.
Prediction Markets Are Where the Action Is. And Trump Media Is Getting In On the Game — Positive
DJT Investopedia — October 28, 2025Digital prediction markets are drawing in throngs of users—and investors.
Here's How Much Traders Expect Amazon Stock To Move After Earnings — Positive
AMZN Investopedia — October 28, 2025Amazon (AMZN) is slated to report third-quarter earnings after the closing bell on Thursday, and some traders are betting the results can give the stock, the laggard of the Magnificent Seven so far this year, a big boost.
LOS ANGELES, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Netflix, Inc., ("Netflix" or the "Company") (NASDAQ: NFLX) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.
Principal Financial Group, Inc. (PFG) Q3 2025 Earnings Call Transcript — Neutral
PFG Seeking Alpha — October 28, 2025Principal Financial Group, Inc. (NASDAQ:PFG ) Q3 2025 Earnings Call October 28, 2025 10:00 AM EDT Company Participants Humphrey Lee - VP & Head of Investor Relations Deanna Strable - President, CEO & Chair of the Board Joel Pitz - Executive VP & CFO Christopher Littlefield - President of Retirement & Income Solutions Amy Friedrich - President of Benefits & Protection Kamal Bhatia - President & CEO of Principal Asset Management Conference Call Participants Francis Matten - BMO Capital Markets Equity Research Ryan Krueger - Keefe, Bruyette, & Woods, Inc., Research Division John Barnidge - Piper Sandler & Co., Research …
BioMarin Beats on Q3 Earnings, Seeks to Divest Hemophilia Gene Therapy — Positive
BMRN Zacks Investment Research — October 28, 2025BMRN tops Q3 earnings expectations but misses on sales. The company moves to divest its hemophilia gene therapy, Roctavian.
PALMDALE, Calif. , Oct. 28, 2025 /PRNewswire/ -- Lockheed Martin Skunk Works® (NYSE: LMT), in partnership with NASA, successfully completed the first flight of the X-59, a revolutionary, quiet supersonic aircraft designed to pave the way for faster commercial air travel.
Shareholder Update Class Action Lawsuit Against Driven Brands Holdings Inc. Survives Motion to Dismiss: Johnson Fistel PLLP Continues to Investigate the Directors and Officers for Breach of Fiduciary Duties — Neutral
DRVN GlobeNewsWire — October 28, 2025SAN DIEGO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces it is investigating whether certain directors and officers of Driven Brands Holdings Inc. (NASDAQ: DRVN) breached their fiduciary duties to the Company and its shareholders.
Can AI create next 'Grand Theft Auto'? Take-Two Interactive CEO says no — Neutral
TTWO CNBC — October 28, 2025The use of AI tools in creative industries including gaming is raising new possibilities, but also perils around copyright infringement and misuse. But at the center of the discussion is AI's creative abilities, and according to Strauss Zelnick, CEO of video game developer Take-Two Interactive, it can't rival human game developers like "Grand Theft Auto" designer Rockstar Games.
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP — Neutral
SLP PRNewsWire — October 28, 2025NEW YORK , Oct. 28, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public. So What: If you purchased Simulations Plus securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Rosen Law Firm Urges DexCom, Inc. (NASDAQ: DXCM) Stockholders with Large Losses to Contact the Firm for Information About Their Rights — Neutral
DXCM Business Wire — October 28, 2025NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of DexCom, Inc. (NASDAQ: DXCM) securities between July 26, 2024 and September 17, 2025, both dates inclusive (the “Class Period”). DexCom is a medical device company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Alleg.
Johnson Fistel Continues Investigation on Behalf of RXO, Inc. (RXO) Shareholders Who Have Incurred Losses — Neutral
RXO GlobeNewsWire — October 28, 2025SAN DIEGO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP, is investigating whether RXO, Inc. (NYSE: RXO) or certain of its officers and directors violated federal securities laws by misrepresenting or failing to timely disclose material information to investors.
SoFi Benefits From Expanding Beyond Lending, Says CEO — Positive
SOFI Bloomberg Technology — October 28, 2025SoFi raised its full year profit outlook and reported increased membership in the last quarter, something CEO Anthony Noto attributed to SoFi's growing range of financial offerings. Noto joins Caroline Hyde and Ed Ludlow on “Bloomberg Tech.
Arcutis Biotherapeutics: Soaring On Q3 Earnings - Further Upside Likely (Upgrade) — Positive
ARQT Seeking Alpha — October 28, 2025Arcutis Biotherapeutics, Inc. surges after Q3 earnings, driven by strong Zoryve sales and outperformance versus Wall Street expectations. ARQT reported $99.2M in Q3 revenue (up 122% YoY), achieved profitability, and projects 2026 revenues of $455M-$470M with cash flow breakeven. Zoryve's expanding indications, large addressable market, and robust prescription growth support a bullish long-term outlook despite competition and reliance on a single product.